Long acting injectable vs. oral antipsychotics in schizophrenia: A systematic review and meta-analysis of cohort studies

Japanese Journal of Neuropsychopharmacology

Volumn 34, Issue 2, 2014, Pages 61-62

  Kishimoto, Taishiro ^a,b,c,d   Nitta, Masahiro ^b,e   Mimura, Masaru ^a   Kane, John M ^b,c,d,f   Correll, Christoph U ^b,c,d,f  

^a KEIO UNIVERSITY   (Japan)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d Feinstein Institute of Medical Research   (United States)

^e DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CONFERENCE PAPER; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SYSTEMATIC REVIEW;

EID: 84901191506     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Kishimoto, T., Robenzadeh, A., Leucht, C., Leucht, S., Watanabe, K., Mimuta, M., Borenstein, M., Kane, J.M. and Correll, C.U. (2013a) Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: A meta-analysis of randomized trials. Schizophr Bull, 39: 1230-1241.
2. Kishimoto, T., Nitta, M., Borenstein, M., Kane, J.M. and Correll, C.U. (2013b) Long acting injectable vs. oral antipsychotics in schizophrenia: A systematic review and meta-analysis of mirror-image studies. J Clin Psychiatry, 74: 957-965.